Search results
Kyowa Kirin Will Present Pre-Clinical Data at the Association for Research in Vision and...
The Yuma Sun· 17 hours agoAge-related macular degeneration (AMD) is a leading cause of severe vision loss for people aged 50 years and older in developed countries worldwide, with ...
EyePoint Pharmaceuticals’ stock plunges as eye treatment fails to meet trial goal
Market Watch· 3 days agodropped nearly 30% in premarket trading Monday after the company said its experimental...
A Revolution In Gene Therapy Is Unfolding, Bringing Hope for Vision Loss
Newswise· 6 days agoTwo treatments for retinal diseases, invented by Neena Haider, PhD, that currently are in clinical trials run by Ocugen, represent a conceptually broad, new approach that ...
Skye Bioscience (NASDAQ:SKYE) Shares Down 1.8%
ETF DAILY NEWS· 10 hours agoSkye Bioscience, Inc. (NASDAQ:SKYE – Get Free Report)’s stock price was down 1.8% during trading on Wednesday . The company traded as low as $12.32 and last traded at $12.50. Approximately 29,170 ...
Research to Prevent Blindness Opens Applications for Vision Research Grants
Newswise· 4 days ago(RPB) is pleased to announce that it has opened a new round of grant funding for high-impact vision research. With a focus on scientific excellence, RPB funds research across all sight-threatening ...
Photography Is a Great Hobby for Retirement. Here’s How to Start.
Good Housekeeping· 20 hours agoRetirement comes with an exciting realization: “Wow, I might actually have some free time!” You’re...
Santa J. Ono, University of Michigan President, Joins USJF Board
FOX 23 News Albany· 2 days agoSanta J. Ono, president of the University of Michigan, has joined the United States-Japan Foundation...
Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat
Zacks via Yahoo Finance· 2 days agoApellis (APLS) reports first-quarter 2024 results, wherein earnings match the Zacks Consensus...
Your Pickleball Checklist
Prevention· 18 hours agoPickleball just can’t seem to stop growing. Part of its mass appeal is its unique accessibility to all ages and skill levels, with small courts that...
Johnson & Johnson Highlights Commitment to Transform Treatment of Retinal Diseases at ARVO 2024
Fontana Herald News· 6 days agoCompany to present, across eight data presentations, new real-world research on the economic value of genetic testing for retinal diseases and the role of automatic deep-learning based algorithms for geographic
